NCT04280601View on ClinicalTrials.gov

PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis

NACompletedINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2023

Conditions

ANCA-associated VasculitisGranulomatosis With PolyangiitisMicroscopic PolyangiitisEosinophilic Granulomatosis With Polyangiitis

Interventions

DIETARY_SUPPLEMENT

vitamin D

Patients with insufficient and/or deficient vitamin D status (\<75 nmol/L) at study enrolment will be instructed to take a 12-month supply of vitamin D3 supplementation (to a maximum of 2,000 IU/day) vs. those with sufficient status will be observed for 12-months

Trial Locations (1)

Unknown

Mount Sinai Hospital, Vasculitis clinic, Toronto

All Listed Sponsors

lead

Christian Pagnoux

OTHER

NCT04280601 - PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis | Biotech Hunter | Biotech Hunter